The Federal Trade Commission’s new acting chair, Rebecca Kelly Slaughter, has initiated a review of the agency's processes for approving pharma mergers. This is expected to result in a tougher road for these mergers, as we explain below. We also look at the top drugs losing their exclusivity this year, ... READ MORE >
5 things to know in life sciences: Week of March 8
This week we look to make sense of COVID-19 variants. We also examine what appears to be heightened scrutiny on accelerated approvals for some treatments, gaps in the understanding of racial and ethnic representation in vaccine trials, tiny cancer-fighting robots and a new contract development and ... READ MORE >
5 things to know in life sciences: Week of March 1
In this week’s roundup we look at new data coming out of the United Kingdom and Israel on their COVID-19 vaccination programs’ results. The U.K. reported last week promising data on the efficacy of the Pfizer-BioNTech vaccine after just one dose. We also highlight improvements in public perception of the ... READ MORE >
5 things to know in life sciences: Week of Feb. 22
In this week’s roundup we look at two important developments in the ongoing response to the pandemic. The first is the likelihood that Johnson & Johnson’s vaccine could be approved under an emergency use authorization (EUA) as early as this weekend. The second is a major new effort by the U.S. ... READ MORE >
5 things to know in life sciences: Week of Feb. 15
In this week’s roundup we look at promising results in a clinical trial leveraging an existing diabetes drug for the treatment of obesity, a new and less invasive treatment for sleep apnea, and a new technology in cardiac catheters. We also examine the impact of the pandemic on oncology trials and the ... READ MORE >
5 things to know in life sciences: Week of Feb. 8
In this week’s roundup, we look at the impact of new COVID-19 variants on existing vaccines for the disease; South Africa made the difficult decision to stop using its most readily available vaccine after it showed limited effectiveness against the variant most common there. This is an important ... READ MORE >
Tech jobs have not been spared in the pandemic, but growth of remote work helps some
Before COVID-19, unemployment in the technology sector was at a five-decade low and was far lower than the overall U.S. unemployment rate. Though unemployment has risen for some parts of the technology sector as the pandemic has gripped the country, companies are still hiring for other roles. Job postings ... READ MORE >